ArticleBMC primary care2025
Importance, facilitators and barriers for finnish general practitioner involvement in clinical practice guideline panels: a survey.
Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Role of General Practitioners in European Health Technology Assessment, EU-HTA Innovation in Oncology as an Example.Journal of market access & health policy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDifficulties in recruiting general practitioners (GPs) to clinical practice guideline panels (CPGPs) have been noted. However, little is known about the specific nature of these challenges. Our objective was to investigate (1) GPs' insights on the importance of their involvement in clinical practice guideline development and (2) the most essential facilitators and barriers related to GPs' involvement in CPGPs.
methodsFor this survey, we invited GPs who had been CPGP members in Current Care Guidelines of Finnish Medical Society Duodecim during the years 2017-2022 (n = 78) to an e-mail survey, which collected information on respondents' backgrounds and aspects of their GP involvement prior to, during, and after the clinical practice guideline process. GPs were identified from the registry of Duodecim. In this article, we report the qualitative analysis of the data. We analysed open-ended questions both deductively (using WONCA core competencies) and inductively regarding the question of important reasons for GP involvement. Facilitators and barriers to involvement were analysed inductively.
resultsOverall, 39 GPs (50.0%) responded. The three most important elements reflecting importance of GPs' involvement in CPGPs were GPs' understanding of primary care management, GPs' role as a major target group of clinical practice guidelines, and GP-specific problem-solving skills. The most important facilitators were information and education related to guideline work, a supportive employer attitude, and financial support. Conversely, lack of time and knowledge regarding the critical appraisal of research evidence were the most important barriers.
conclusionGPs' involvement in CPGPs should be supported by strengthening the promotive factors and reducing barriers to participation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.